These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 21895989)

  • 21. Complete remission in advanced blastic NK-cell lymphoma/leukemia in elderly patients using the hyper-CVAD regimen.
    Shapiro M; Wasik MA; Junkins-Hopkins JM; Rook AH; Vittorio CC; Itakura H; Frankel MC; Georgala S; Schuster SJ
    Am J Hematol; 2003 Sep; 74(1):46-51. PubMed ID: 12949889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NK and NK-related neoplasms.
    Mori N
    Nagoya J Med Sci; 1999 Nov; 62(3-4):99-106. PubMed ID: 10689871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blastic natural killer cell lymphoma/leukemia (CD56-positive blastic tumor): prognostication and categorization according to anatomic sites of involvement.
    Suzuki R; Nakamura S; Suzumiya J; Ichimura K; Ichikawa M; Ogata K; Kura Y; Aikawa K; Teshima H; Sako M; Kojima H; Nishio M; Yoshino T; Sugimori H; Kawa K; Oshimi K;
    Cancer; 2005 Sep; 104(5):1022-31. PubMed ID: 15999368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cutaneous T-cell and NK-cell lymphomas: the WHO-EORTC classification and the increasing recognition of specialized tumor types.
    Kinney MC; Jones D
    Am J Clin Pathol; 2007 May; 127(5):670-86. PubMed ID: 17439828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Malignant lymphoma and leukemia concepts in new WHO classification].
    Kikuchi M
    Rinsho Byori; 2003 Aug; 51(8):820-4. PubMed ID: 13677944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The World Health Organization (WHO) classification of tumors of the hematopoietic and lymphoid tissues: an overview with emphasis on the myeloid neoplasms.
    Vardiman JW
    Chem Biol Interact; 2010 Mar; 184(1-2):16-20. PubMed ID: 19857474
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [NK-cell lymphomas and NK-like T-cell lymphomas].
    Oshimi K
    Nihon Rinsho; 2000 Mar; 58(3):646-9. PubMed ID: 10741139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
    Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
    Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The World Health Organization classification of malignant lymphoma: incidence and clinical prognosis in HTLV-1-endemic area of Fukuoka.
    Ohshima K; Suzumiya J; Kikuchi M
    Pathol Int; 2002 Jan; 52(1):1-12. PubMed ID: 11940200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder.
    Huang Q; Chang KL; Gaal KK; Weiss LM
    Am J Surg Pathol; 2005 Nov; 29(11):1540-3. PubMed ID: 16224224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural killer cell neoplasm: biology and pathology.
    Ham MF; Ko YH
    Int J Hematol; 2010 Dec; 92(5):681-9. PubMed ID: 21132576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blastic NK-cell-like lymphoma with T-cell receptor gene rearrangement.
    Liu XY; Atkins RC; Feusner JH; Rowland JM
    Am J Hematol; 2004 Apr; 75(4):251-3. PubMed ID: 15054822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lymphoproliferative disorder of granular lymphocytes: nine cases including one with features of CD56 (NKH1)-positive aggressive natural killer cell lymphoma.
    Nichols GE; Normansell DE; Williams ME
    Mod Pathol; 1994 Oct; 7(8):819-24. PubMed ID: 7530849
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blastic natural killer cell leukemia/lymphoma presenting as overt leukemia.
    Alvarez-Larrán A; Villamor N; Hernández-Boluda JC; Ferrer A; Camós M; Campo E; López-Guillermo A
    Clin Lymphoma; 2001 Dec; 2(3):178-82; discussion 183-4. PubMed ID: 11779295
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
    Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural killer cell lymphoma/leukemia: pathology and treatment.
    Kwong YL; Chan AC; Liang RH
    Hematol Oncol; 1997 May; 15(2):71-9. PubMed ID: 9375032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
    Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
    J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Childhood blastic NK cell leukemia successfully treated with L-asparagenase and allogeneic bone marrow transplantation.
    Hyakuna N; Toguchi S; Higa T; Okudaira T; Taira N; Masuda M; Kitoh T; Ohta T
    Pediatr Blood Cancer; 2004 Jun; 42(7):631-4. PubMed ID: 15127419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NK-cell neoplasms in Japan.
    Oshimi K; Kawa K; Nakamura S; Suzuki R; Suzumiya J; Yamaguchi M; Kameoka J; Tagawa S; Imamura N; Ohshima K; Kojya S; Iwatsuki K; Tokura Y; Sato E; Sugimori H;
    Hematology; 2005 Jun; 10(3):237-45. PubMed ID: 16019472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Precursor natural killer cell leukemia.
    Liang X; Greffe B; Garrington T; Graham DK
    Pediatr Blood Cancer; 2008 Apr; 50(4):876-8. PubMed ID: 17417789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.